Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroblastoma (NBL)”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Looking for participantsNCT05642455
What this trial is testing

SPEARHEAD-3 Pediatric Study

Who this might be right for
Synovial SarcomaMalignant Peripheral Nerve Sheath Tumor (MPNST)Neuroblastoma (NBL)+1 more
USWM CT, LLC 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04385277
What this trial is testing

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

Who this might be right for
Ganglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 41
Not applicableNo Longer AvailableNCT07223606
What this trial is testing

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

Who this might be right for
NeuroblastomaNeuroblastoma (NB)Neuroblastoma (NBL)+4 more
ProgenaBiome
Large-scale testing (Phase 3)Looking for participantsNCT03126916
What this trial is testing

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Who this might be right for
GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 750
Testing effectiveness (Phase 2)WithdrawnNCT00874315
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Who this might be right for
Neuroblastoma
Nationwide Children's Hospital